New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
08:58 EDTBTXBioTime receives ISO 13485 certification for medical devices
BioTime announced that it has received ISO 13485:2003 certification from British Standards Institution for design, development, manufacture, and distribution of BioTime HyStem hydrogels for cell delivery applications. If Renevia is approved for the treatment of HIV-related facial lipoatrophy, BioTime plans to seek to expand its uses into other cell-based applications in reconstructive surgeries, traumatic injuries, and age-related lipoatrophy. BioTime’s plan is to bring Renevia to the medical market first in the E.U., where the regulatory pathway will allow for faster approval than in the U.S. Once the use of Renevia is established in Europe, BioTime will address an even larger potential market in Asia and the U.S.
News For BTX From The Last 14 Days
Check below for free stories on BTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
09:01 EDTBTXBioTime announces collaboration with University of Wisconsin, Louvain University
Subscribe for More Information
August 27, 2014
09:02 EDTBTXBioTime unit receives FDA clearance to initiate Phase 1/2a trial of AST-OPC1
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use